<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.peertechzpublications.org/assets/xsl/oaitohtml.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
										<responseDate>2026-08-19T10:16:12Z</responseDate>
										<request verb="GetRecord" metadataPrefix="oai_dc" identifier="oai:www.peertechzpublications.org:10.17352/jgro.000016">https://www.peertechzpublications.org/oai-pmh</request><GetRecord><record>
								<header>
									<identifier>oai:www.peertechzpublications.org:10.17352/jgro.000016</identifier>
									<datestamp>2016-06-21</datestamp>
									<setSpec>PTZ.JGRO:VOL2</setSpec>
								</header>
								<metadata>
									<oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
										<dc:title>
										The Expression of Apolipoprotein A1  on Pregnancy Outcome in Women  with Polycystic Ovary Syndrome  Compared to Fertile Women: A  Cross-Sectional Study
										</dc:title><dc:creator>Fathy H</dc:creator><dc:description>&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To explore the level of apolipoprotein A1 expression in human endometrial tissues in
women with polycystic ovary syndrome compared to fertile women.&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Patients and Methods:&lt;/strong&gt; This was a cross sectional study performed at Ain Shams University
Maternity Hospital, over a 2-year period, between Jan 2014 and Jan 2016, and included 80 women
divided into two groups. Group I (n=40) with polycystic ovary syndrome who were presented at the
infertility clinic and group II (n=40) fertile women who were presented due to any cause other than
infertility as a control group. All women were scheduled for endometrial sampling by Endosampler.
Participant ages ranged from 20 to 35 years. A written informed consent was obtained from all women
before participation. Endometrial apolipoprotein A1 was investigated using ELIZA. Samples were
obtained from all patients in the proliferative phase (just before ovulation when the dominant follicle is
20 mm) and secretory phase (5 days after the 1st sample).&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results:&lt;/strong&gt; In this study, endometrial apolipoprotein A1 expression was up regulated in patients with
polycystic ovary syndrome compared to normal subjects, also the level was higher in the proliferative
phase when compared to the secretory phase (P value &amp;lt; 0.05).&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions:&lt;/strong&gt; It seems that differentially expressed apolipoprotein A1 negatively affects
endometrial receptivity in patients with polycystic ovary syndrome. The results showed that
apolipoprotein A1 level significantly changes in the human endometrium during the menstrual cycle
with minimum expression in the secretory phase, coincident with the receptive phase (window of
implantation).&lt;/p&gt;</dc:description>
										<dc:publisher>Journal of Gynecological Research and Obstetrics - Peertechz Publications</dc:publisher>
										<dc:date>2016-06-21</dc:date>
										<dc:type>Research Article</dc:type>
										<dc:identifier>https://doi.org/10.17352/jgro.000016</dc:identifier>
										<dc:language>en</dc:language>
										<dc:rights>Copyright © Fathy H et al.</dc:rights>
									</oai_dc:dc>
								</metadata>
							</record></GetRecord>
						</OAI-PMH>
